Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes

Molecular Neurobiology

Volumn 52, Issue 2, 2015, Pages 805-810

  Oxenkrug, Gregory F ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Kynurenic acid; Kynurenines; Stress; Tryptophan; Type 2 diabetes; Xanthurenic acid

Indexed keywords

3 HYDROXYANTHRANILIC ACID; GLUCOSE; KYNURENIC ACID; KYNURENINE; METFORMIN; TRYPTOPHAN; XANTHURENIC ACID; ANTIDIABETIC AGENT; INDOLEAMINE 2,3 DIOXYGENASE; PYRIDOXAL 5 PHOSPHATE; TRYPTOPHAN 2,3 DIOXYGENASE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; AGED; BLOOD; DIABETES MELLITUS, TYPE 2; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; METABOLISM; MIDDLE AGED; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

3-HYDROXYANTHRANILIC ACID; ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; KYNURENIC ACID; KYNURENINE; MALE; METFORMIN; MIDDLE AGED; PREDIABETIC STATE; PYRIDOXAL PHOSPHATE; STRESS, PHYSIOLOGICAL; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; XANTHURENATES;

EID: 84940793953     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9232-0     Document Type: Article

References (34)

1. Hackett RA, Steptoe A, Kumari M (2014) Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J Clin Endocrinol Metab 99:4625–4631. doi:10.1210/jc.2014-2459
2. Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219–246
3. Connick JH, Stone TW (1985) The role of kynurenines in diabetes mellitus. Med Hypotheses 18:371–376
4. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465–477
5. Alberati-Giani D, Ricciardi-Castagnoli P, Kohler C, Cesura AM (1996) Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J Neurochem 66:996–1004
6. Musajo L (1935) L’acido xanthurenico. Rend Accad Nazl Lincci 21:368–371
7. Mahuren JD, Dubeski PL, Cook NJ, Schaefer AL, Coburn SP (1999) Adrenocorticotropic hormone increases hydrolysis of B-6 vitamers in swine adrenal glands. J Nutr 129:1905–1908
8. Paul L, Ueland PM, Selhub J (2013) Mechanistic perspective on the relationship between pyridoxal 5′-phosphate and inflammation. Nutr Rev 71:239–244
9. Rios-Avila L, Nijhout HF, Reed MC, Sitren HS, Gregory JF 3rd (2013) A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into the effects of vitamin B-6 deficiency, tryptophan loading, and induction of tryptophan 2,3-dioxygenase on tryptophan metabolites. J Nutr 143:1509–1519. doi:10.3945/jn.113.174599
10. Kotake Y (1955) Xanthurenic acid, an abnormal metabolite of tryptophan and the diabetic symptoms caused in albino rats by its production. J Vitaminol (Kyoto) 1:73–87
11. Ikeda S, Kotake Y (1984) Urinary excretion of xanthurenic acid and zinc in diabetes: 1 separation of xanthurenic acid-Zn2+ complex by ion-exchange chromatography. Acta Vitaminol Enzymol 6:23–28
12. Okamoto H (1981) Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 37:43–61
13. Murakami E, Kotake Y (1972) Studies on the xanthurenic acid-insulin complex. 3. Distribution of xanthurenic acid and formation of xanthurenic acid-insulin complex in serum. J Biochem 72:251–259
14. Meyramov G, Korchin V, Kocheryzkina N (1998) Diabetogenic activity of xanturenic acid determined by its chelating properties? Transplant Proc 30:2682–2684
15. Oxenkrug G (2013) Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol 48:294–301. doi:10.1007/s12035-013-8497-4
16. Oxenkrug GF, Turski WA, Zgrajka W, Weinstock JV, Summergrad P (2013) Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients. Hepat Res Treat 2013: 149247
17. Manusadzhian VG, Kniazev IA, Vakhrusheva LL (1974) Mass spectrometric identification of xanthurenic acid in pre-diabetes. Vopr Med Khim 20:95–97
18. Midttun O, Ulvik A, Pedersen E, Ebbing M, Bleie O et al (2011) Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J Nutr 141:611–617
19. Marchetti P, Masiello P, Benzi L, Cecchetti P, Fierabracci V, Giannarelli R, Gregorio F, Brunetti P et al (1989) Effects of metformin therapy on plasma amino acid pattern in patients with maturity-onset diabetes. Drugs Exp Clin Res 15:565–570
20. Do MT, Kim HG, Tran TT, Khanal T, Choi JH, Chung YC, Jeong TC, Jeong HG (2014) Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression. Toxicol Appl Pharmacol 280:138–148. doi:10.1016/j.taap.2014.07.021
21. Khattab M, Abul-Fadl M, Khalafallah A, Hamza S (1972) Studies on the urinary excretion of certain tryptophan metabolites in diabetics. J Egypt Med Assoc 55:531–541
22. Calandra P (1977) Identification of tryptophan metabolites in the healthy epidermis of diabetics. Acta Diabetol Lat 14:1426-37
23. Munipally PK, Agraharm SG, Valavala VK, Gundae S, Turlapati NR (2011) Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients. Arch Physiol Biochem 117:254–258. doi:10.3109/13813455.2011.623705
24. Hayaishi O (1976) Properties and function of indoleamine 2,3-dioxygenase. J Biochem 79:13–21
25. Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D, Brandacher G (2010) Neopterin, a prognostic marker in human malignancies. Cancer Lett 287:13–22
26. Oxenkrug G, Tucker KL, Requintina P, Summergrad P (2011) Neopterin, a marker of interferon-gamma-inducible inflammation, correlates with pyridoxal-5′-phosphate, waist circumference, HDL-cholesterol, insulin resistance and mortality risk in adult Boston community dwellers of Puerto Rican origin. Am J Neuroprot Neuroregen 3:48–52
27. Shibata K, Mushiage M, Kondo T, Hayakawa T, Tsuge H (1955) Effects of vitamin B6 deficiency on the conversion ratio of tryptophan to niacin. Biosci Biotechnol Biochem 59:2060–2063
28. Yeh JK, Brown RR (1977) Effects of vitamin B-6 deficiency and tryptophan loading on urinary excretion of tryptophan metabolites in mammals. J Nutr 107:261–271
29. Bender DA, Njagi EN, Danielian PS (1990) Tryptophan metabolism in vitamin B6-deficient mice. Br J Nutr 63:27–36
30. Midttun O, Ulvik A, Ringdal Pedersen E, Ebbing M, Bleie O, Schartum-Hansen H, Nilsen RM, Nygard O et al (2011) Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J Nutr 141:611–617
31. Pedersen ER, Tuseth N, Eussen SJ, Ueland PM, Strand E, Svingen GF, Midttun Ø, Meyer K et al (2015) Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Biol 35:455–462. doi:10.1161/ATVBAHA.114.304674
32. Oxenkrug G, Ratner R, Summergrad P (2013) Kynurenines and vitamin B6: link between diabetes and depression. J Bioinformatics Diabetes 1:1–9. doi:10.14302/issn.2374-9431.jbd-13-212
33. Oxenkrug G (2015) 3-Hydroxykynurenic acid and type 2 diabetes: implications for aging, obesity, depression, Parkinson’s disease and schizophrenia. In: Engin A, Engin AB (eds) Tryptophan metabolism: implications for biological processes, health and diseases, molecular and integrative toxicology. Springer International Publishing, Switzerland, pp 173–195. doi:10.1007/978-3-319-15630-9_8
34. Polyzos KA, Ketelhuth DF (2015) The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field. Hamostaseologie 35:128–136. doi:10.5482/HAMO-14-10-00562